Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
388
datasets available to search
ShareScore release 0.7.1
Dataset results
388 results for “alcoholic fatty liver disease”
Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT04857606. IPD Sharing: YES. Countries: 1. Publications: 0.
Selenoprotein P and Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01257685. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Smartphone App for Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT05180760. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT00816465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
ClinicalTrials.gov study NCT05849220. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT02520609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetic Studies of Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01629095. IPD Sharing: Not stated. Countries: 1. Publications: 0.
C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT02083159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT05517564. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03307408. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Co
ClinicalTrials.gov study NCT06649162. IPD Sharing: NO. Countries: 1. Publications: 0.
Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT05741957. IPD Sharing: YES. Countries: 1. Publications: 0.
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia
ClinicalTrials.gov study NCT05464784. IPD Sharing: NO. Countries: 1. Publications: 0.
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
ClinicalTrials.gov study NCT04550481. IPD Sharing: YES. Countries: 1. Publications: 0.
Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
ClinicalTrials.gov study NCT00152815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients
ClinicalTrials.gov study NCT04462081. IPD Sharing: NO. Countries: 1. Publications: 0.
Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements
ClinicalTrials.gov study NCT05810506. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT00815009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT05067621. IPD Sharing: NO. Countries: 1. Publications: 0.
Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients
ClinicalTrials.gov study NCT00844779. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.